442 related articles for article (PubMed ID: 31767844)
1. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
[TBL] [Abstract][Full Text] [Related]
2. CRISPR Base Editing in Induced Pluripotent Stem Cells.
Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
[TBL] [Abstract][Full Text] [Related]
3. High-Fidelity Cytosine Base Editing in a GC-Rich Corynebacterium glutamicum with Reduced DNA Off-Target Editing Effects.
Heo YB; Hwang GH; Kang SW; Bae S; Woo HM
Microbiol Spectr; 2022 Dec; 10(6):e0376022. PubMed ID: 36374037
[TBL] [Abstract][Full Text] [Related]
4. MagnEdit-interacting factors that recruit DNA-editing enzymes to single base targets.
McCann JL; Salamango DJ; Law EK; Brown WL; Harris RS
Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32094150
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
Kim D; Lim K; Kim ST; Yoon SH; Kim K; Ryu SM; Kim JS
Nat Biotechnol; 2017 May; 35(5):475-480. PubMed ID: 28398345
[TBL] [Abstract][Full Text] [Related]
6. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells.
Kurt IC; Zhou R; Iyer S; Garcia SP; Miller BR; Langner LM; Grünewald J; Joung JK
Nat Biotechnol; 2021 Jan; 39(1):41-46. PubMed ID: 32690971
[TBL] [Abstract][Full Text] [Related]
7. Off-target effects of base editors: what we know and how we can reduce it.
Slesarenko YS; Lavrov AV; Smirnikhina SA
Curr Genet; 2022 Feb; 68(1):39-48. PubMed ID: 34515826
[TBL] [Abstract][Full Text] [Related]
8. Expanding C-T base editing toolkit with diversified cytidine deaminases.
Cheng TL; Li S; Yuan B; Wang X; Zhou W; Qiu Z
Nat Commun; 2019 Aug; 10(1):3612. PubMed ID: 31399578
[TBL] [Abstract][Full Text] [Related]
9. Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing.
Chen L; Zhu B; Ru G; Meng H; Yan Y; Hong M; Zhang D; Luan C; Zhang S; Wu H; Gao H; Bai S; Li C; Ding R; Xue N; Lei Z; Chen Y; Guan Y; Siwko S; Cheng Y; Song G; Wang L; Yi C; Liu M; Li D
Nat Biotechnol; 2023 May; 41(5):663-672. PubMed ID: 36357717
[TBL] [Abstract][Full Text] [Related]
10. Glycosylase base editors enable C-to-A and C-to-G base changes.
Zhao D; Li J; Li S; Xin X; Hu M; Price MA; Rosser SJ; Bi C; Zhang X
Nat Biotechnol; 2021 Jan; 39(1):35-40. PubMed ID: 32690970
[TBL] [Abstract][Full Text] [Related]
11. CRISPR DNA base editors with reduced RNA off-target and self-editing activities.
Grünewald J; Zhou R; Iyer S; Lareau CA; Garcia SP; Aryee MJ; Joung JK
Nat Biotechnol; 2019 Sep; 37(9):1041-1048. PubMed ID: 31477922
[TBL] [Abstract][Full Text] [Related]
12. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cytosine base editors and development of the BEable-GPS database for targeting pathogenic SNVs.
Wang Y; Gao R; Wu J; Xiong YC; Wei J; Zhang S; Yang B; Chen J; Yang L
Genome Biol; 2019 Oct; 20(1):218. PubMed ID: 31647030
[TBL] [Abstract][Full Text] [Related]
14. Off-Target Editing by CRISPR-Guided DNA Base Editors.
Park S; Beal PA
Biochemistry; 2019 Sep; 58(36):3727-3734. PubMed ID: 31433621
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of base editors with anti-deaminases derived from viruses.
Liu Z; Chen S; Lai L; Li Z
Nat Commun; 2022 Feb; 13(1):597. PubMed ID: 35105899
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
Molla KA; Yang Y
Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
[TBL] [Abstract][Full Text] [Related]
17. Improved plant cytosine base editors with high editing activity, purity, and specificity.
Ren Q; Sretenovic S; Liu G; Zhong Z; Wang J; Huang L; Tang X; Guo Y; Liu L; Wu Y; Zhou J; Zhao Y; Yang H; He Y; Liu S; Yin D; Mayorga R; Zheng X; Zhang T; Qi Y; Zhang Y
Plant Biotechnol J; 2021 Oct; 19(10):2052-2068. PubMed ID: 34042262
[TBL] [Abstract][Full Text] [Related]
18. High-efficient and precise base editing of C•G to T•A in the allotetraploid cotton (Gossypium hirsutum) genome using a modified CRISPR/Cas9 system.
Qin L; Li J; Wang Q; Xu Z; Sun L; Alariqi M; Manghwar H; Wang G; Li B; Ding X; Rui H; Huang H; Lu T; Lindsey K; Daniell H; Zhang X; Jin S
Plant Biotechnol J; 2020 Jan; 18(1):45-56. PubMed ID: 31116473
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
20. The "new favorite" of gene editing technology-single base editors.
Wei Y; Zhang XH; Li DL
Yi Chuan; 2017 Dec; 39(12):1115-1121. PubMed ID: 29258982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
